The University of Maryland School of Medicine, located in Baltimore City, Maryland, U.S., is the medical school of the University of Maryland, Baltimore and is affiliated with the University of Maryland Medical Center and Medical System.

During the past decade, University of Maryland School of Medicine conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 35 clinical trials were completed, i.e. on average, 53% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 19 clinical trials were completed. i.e. 57.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Maryland School of Medicine" #1 sponsor was "University of Maryland, Baltimore" with 24 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 11 trials sponsored, "University of North Carolina, Chapel Hill" with 6 trials sponsored, "Actelion" with 5 trials sponsored and "Celgene" with 5 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 79 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Maryland School of Medicine" #1 collaborator was "National Institute of Mental Health (NIMH)" with 6 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 6 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator. Other collaborators include 105 different institutions and companies that were collaborators in the rest 92 trials.

According to Clinical.Site data, the most researched conditions in "University of Maryland School of Medicine" are "Pulmonary Arterial Hypertension" (5 trials), "Depression" (4 trials), "HIV" (4 trials), "HIV Infections" (4 trials) and "Influenza" (4 trials). Many other conditions were trialed in "University of Maryland School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Maryland School of Medicine" are "Drug" (71 trials), "Other" (28 trials), "Biological" (22 trials), "Behavioral" (16 trials) and "Device" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "placebo" (6 trials), "AS03" (2 trials), "Anginera, a human tissue replacement therapy" (2 trials) and "CC-220" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Maryland School of Medicine" are 140 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Maryland School of Medicine". undefined are not yet recruiting, 26 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 82 completed trials in University of Maryland School of Medicine, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University of Maryland School of Medicine, 19 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 28 trials that are defined as “Not Applicable".